Karydas Daphne 4
4 · LogicBio Therapeutics, Inc. · Filed Dec 14, 2020
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2020-12-10+20,000→ 20,000 totalExercise: $7.36Exp: 2030-12-10→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, December 10, 2020.